HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

After Leaving Prison, Former USPlabs Executive Will Have To Wait 4 Years To Import Supplements

Executive Summary

FDA debars Jonathan Doyle for five years from importing food in US due to 2020 conviction through a guilty plea on a felony federal charge. Doyle scheduled for release from prison in September 2022; sentences for some co-defendants end sooner, some later.

You may also be interested in...



Food Importing Unlikely For USPlabs Owner's Future

FDA debars Matthew Hebert, USPlabs co-owner “with primarily responsibilities over product packaging design,” for five years from importing dietary ingredients or other articles of food.

HBW People News: Changes At NOW Health, Herbalife, AHPA, And Prison For USPLabs

NOW Health promotes Secrist, hires Carney; Herbalife adds chief risk officer post; AHPA promotes Bennett to lead marketing, engagement; BBB National Programs expands leadership; and USPLabs executives sentenced to prison.

DoJ Prosecutions: USPlabs Guilty, DMBA Firm Indicted From FDA Investigations

USPlabs executives, others plead guilty to felony charges stemming from marketing unsafe products labeled as supplements but containing DMAA and linked to hepatitis. Blackstone Labs and other firms indicted on felony charges following FDA investigation for marketing DMBA-containing products. "It's all very welcome news, but I'm not sure this is going to change the overall environment," says Pieter Cohen, a physician who advocates for tighter regulation of supplement manufacturing and marketing.

Related Content

Topics

UsernamePublicRestriction

Register

RS151581

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel